Durability of Clinical Benefit and Biomarkers in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Sotorasib, a KRAS(G12C) Inhibitor

Hong, D. S.; Bang, Yung-Jue; Barlesi, F.; Durm, G.; Falchook, G.; Govindan, R.; Dy, G.; Park, K.; Strickler, J.; Burns, T.; Kim, J.; Ang, A.; Lipford, J. R.; Ngarmchamnanrith, G.; Anderson, A.; Li, B. T.

doi:10.1016/j.jtho.2020.10.136

서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

S-Space

Publications

Detailed Information

Durability of Clinical Benefit and Biomarkers in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Sotorasib, a KRAS(G12C) Inhibitor

Cited 1 time in Web of Science Cited 0 time in Scopus

Export

Authors: Hong, D. S.; Bang, Yung-Jue; Barlesi, F.; Durm, G.; Falchook, G.; Govindan, R.; Dy, G.; Park, K.; Strickler, J.; Burns, T.; Kim, J.; Ang, A.; Lipford, J. R.; Ngarmchamnanrith, G.; Anderson, A.; Li, B. T.